(Q41418345)

30 September 2017

1 reference

title

Fungal infections in patients with acquired immunodeficiency syndrome (English)

1 reference

30 September 2017

Minamoto GY

1

1 reference

PubMed ID

9093234

30 September 2017

Rosenberg AS

series ordinal

2

1 reference

30 September 2017

1 March 1997

1 reference

Medical Clinics of North America

30 September 2017

1 reference

30 September 2017

81

1 reference

30 September 2017

2

1 reference

30 September 2017

381-409

1 reference

Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Systemic infection caused by Penicillium decumbens in a patient with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Common superficial fungal infections in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Central nervous system histoplasmosis. An unappreciated complication of the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Treatment of infections in patients with the acquired immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcus neoformans myositis in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Bacterial, viral, fungal, and parasitic infections in HIV disease and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole-resistant Candida albicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole Treatment of Persistent Cryptococcus neoformans Prostatic Infection in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis and blastomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Ketoconazole therapy for endemic blastomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Adrenocortical lesions and AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Coccidioidomycosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cardiac lesions in acquired immune deficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Extensive gastrointestinal aspergillosis associated with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary Aspergillosis, Inhalation of Contaminated Marijuana Smoke, Chronic Granulomatous Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cutaneous cryptococcosis mimicking molluscum contagiosum in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Medical management of AIDS patients. Bacterial and fungal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole therapy for cryptococcal meningitis and cryptococcosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcal meningitis in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Management of cryptococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Spontaneous Candida albicans meningitis in a patient with the acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Coccidioidomycosis: new aspects of epidemiology and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcal infections in patients with acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Treatment of seborrhoeic dermatitis with topical ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

The response of seborrhoeic dermatitis to ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated histoplasmosis in AIDS: an unusual case of esophageal involvement and gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Coccidioidomycosis in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Severe Candida krusei infection in an AIDS patient receiving long-term treatment with fluconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Colonic histoplasmosis in acquired immunodeficiency syndrome. Report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

Histoplasmosis and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Treatment of oropharyngeal candidiasis in HIV-positive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Diabetic ketoacidosis and invasive aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis presenting with unusual skin lesions in acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Candida albicans endophthalmitis in a patient with AIDS. Case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis diagnosed on peripheral blood smear from a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cardiac aspergillosis in acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Hierarchical pattern of mucosal candida infections in HIV-seropositive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Maculopapular rash in a patient with acquired immunodeficiency syndrome. Disseminated histoplasmosis in acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Aspergillosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

AIDS: cardiac findings from 115 autopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Treatment of systemic fungal infections with liposomal amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis in patients with the acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Goiter as a manifestation of disseminated aspergillosis in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis in patients with AIDS: efficacy of maintenance amphotericin B therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Candidal pyarthrosis in an AIDS patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Invasive aspergillosis in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Aspergillosis of the cerebral ventricles in a heroin abuser. Case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary infectious complications of human immunodeficiency virus infection. Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Blastomycosis in patients with the acquired immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Blastomycosis in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Esophageal candidiasis in the diagnosis of HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcal meningitis and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Editorial response: management of cryptococcal meningitis--have we answered all the questions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Aspergillus species colonization and invasive disease in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated histoplasmosis: abdominal CT findings in 16 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Catastrophic visual loss due to Cryptococcus neoformans meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Resistance of Candida species to fluconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Clinical epidemiological study of 171 cases of cryptococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Oral aspergillosis in a patient with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated histoplasmosis in patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Classical complement pathway in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Penicillium marneffei Infection in Patients Infected with Human Immunodeficiency Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated Penicillium marneffei infection in southeast Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Aspergillus sinusitis in patients with AIDS: report of three cases and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole therapy for chronic coccidioidal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Disease-Specific Recommendations*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Isolated kidney localization of invasive Aspergillosis in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Pulmonary cryptococcosis in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Disseminated histoplasmosis presenting as a rosacea-like eruption in a patient with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Is vulvovaginal candidiasis an AIDS-related illness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Esophageal disease in the acquired immunodeficiency syndrome: etiology, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Acquired immune deficiency syndrome presenting as bone marrow and mediastinal cryptococcosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Serodiagnosis of Penicillium marneffei infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

Aspergillosis. The spectrum of the disease in 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970523-X

7 January 2021

10.1016/S0025-7125(05)70523-X

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9093234